Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma (Hepatoma)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02638857
What this trial is testing

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Recurrence Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Second Military Medical University 60
Testing effectiveness (Phase 2)Study completedNCT04710641
What this trial is testing

Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone

Who this might be right for
Hepatocellular CarcinomaHepatitis BHepatitis C
Mina Alpha Limited 8
Not applicableUnknownNCT01957241
What this trial is testing

PLA for HCC and Esophageal ca Serum

Who this might be right for
Hepatocellular CarcinomaEsophageal Cancer
National Taiwan University Hospital 164
Not applicableLooking for participantsNCT06486454
What this trial is testing

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Who this might be right for
Liver NeoplasmsPrimary Liver CancerSecondary Liver Cancer+2 more
HistoSonics, Inc. 5,000
Testing effectiveness (Phase 2)UnknownNCT03825705
What this trial is testing

A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma

Who this might be right for
Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Not applicableStudy completedNCT03564405
What this trial is testing

Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Jeil Pharmaceutical Co., Ltd. 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078305
What this trial is testing

Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 134
Not applicableLooking for participantsNCT05661786
What this trial is testing

Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase

Who this might be right for
Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 4,500
Early research (Phase 1)Study completedNCT01129570
What this trial is testing

Siliphos in Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Abby Siegel 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT06779461
What this trial is testing

A Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-Resectable
InnoBM Pharmaceuticals Co., Ltd. 228
Testing effectiveness (Phase 2)Looking for participantsNCT07047586
What this trial is testing

Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab

Who this might be right for
Hepatocellular Carcinoma (HCC)
Fudan University 146
Testing effectiveness (Phase 2)Study completedNCT03586973
What this trial is testing

Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Takeda 34
Not applicableStudy completedNCT01361061
What this trial is testing

AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver

Who this might be right for
Liver Cirrhosis
University Hospital Freiburg 450
Not applicableLooking for participantsNCT05887661
What this trial is testing

Goal-directed LCVP Based on HP in Laparoscopic Hepatectomy

Who this might be right for
Hepatocellular Carcinoma
The First Affiliated Hospital with Nanjing Medical University 100
Post-approval studies (Phase 4)UnknownNCT01570075
What this trial is testing

Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 180
Not applicableUnknownNCT04813432
What this trial is testing

Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas

Who this might be right for
Contrast MediaComputed TomographyImaging+2 more
Karolinska Institutet 50
Not applicableLooking for participantsNCT06550921
What this trial is testing

Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaOligometastasisAblation+2 more
Sun Yat-sen University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03186898
What this trial is testing

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v7Unresectable Hepatocellular Carcinoma
NRG Oncology 115
Not applicableStudy completedNCT03254121
What this trial is testing

Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response

Who this might be right for
Hepatocellular CarcinomaHepatitis C
Karolinska Institutet 93
Next Page